-
Deep Learning Tool Empowers Biologists, Speeds Screening
Bio-IT World | Traditional high content screening is labor- and time-intensive, and many groups are working to apply deep learning to image analysis. Genedata worked with AstraZeneca to validate a deep learning workflow tool for biologists that can be “unsupervised”—it works without re-engineering across different assay types and settings.
Jun 25, 2018
-
Challenges In Bringing Personalized Cancer Vaccines To The Clinic
Bio-IT World Contributed Commentary | The cancer vaccine industry faces a challenge: How to transition from prediction to effective vaccine therapy?
Jun 21, 2018
-
Alexion’s Quest To Test The Algorithm Of Rare Disease Diagnosis
Bio-IT World | Alexion, in collaboration with EPAM, has developed a software competition platform to allow the objective comparison of contributed algorithms for automated rare disease diagnosis.
Jun 20, 2018
-
Roche Pays $2.4 Billion For Rest Of Cancer Expert Foundation Medicine
Reuters | Swiss drugmaker Roche is paying $2.4 billion to buy the rest of Foundation Medicine, raising its bet on the U.S. genomic profiling group's ability to personalize cancer care.
Jun 19, 2018
